Obesity and cancer: mechanistic insights from transdisciplinary studies

作者: Emma H Allott , Stephen D Hursting

DOI: 10.1530/ERC-15-0400

关键词:

摘要: Obesity is associated with a range of health outcomes that are clinical and public significance, including cancer. Herein, we summarize epidemiologic preclinical evidence for an association between obesity increased risk breast prostate cancer incidence mortality. Moreover, describe data from observational studies weight change in humans calorie-restriction mouse models support potential role loss counteracting tumor-promoting properties cancers. Given challenging to achieve maintain, also consider linking treatments obesity-associated co-morbidities, metformin, statins non-steroidal anti-inflammatory drugs, reduced Finally, highlight several challenges should be considered when conducting research the area cancer, measurement population-based studies, timing relation tumor latency diagnosis, heterogeneous nature its co-morbidities. complex trait, comprised behavioral, molecular/metabolic factors, argue transdisciplinary approach key understanding mechanisms As such, this review highlights critical need integrate both gain insight into biologic non-biologic contributing obesity-cancer link.

参考文章(260)
Mohana Roy, Paramita M Ghosh, Hsing-Jien Kung, Statins and prostate cancer: role of cholesterol inhibition vs. prevention of small GTP-binding proteins. American Journal of Cancer Research. ,vol. 1, pp. 542- 561 ,(2011)
Ryne Paulose-Ram, Vicki L Burt, Brian K Kit, Qiuping Gu, Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003-2012. NCHS data brief. pp. 1- 8 ,(2014)
Stefanos Bonovas, Kalitsa Filioussi, Nikolaos M. Sitaras, Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies. International Journal of Cancer. ,vol. 123, pp. 899- 904 ,(2008) , 10.1002/IJC.23550
Melanie Clyne, Prostate cancer: metformin--the new wonder drug? Nature Reviews Urology. ,vol. 11, pp. 366- 366 ,(2014) , 10.1038/NRUROL.2014.136
Hutan Ashrafian, Kamran Ahmed, Simon P. Rowland, Vanash M. Patel, Nigel J. Gooderham, Elaine Holmes, Ara Darzi, Thanos Athanasiou, Metabolic surgery and cancer: protective effects of bariatric procedures. Cancer. ,vol. 117, pp. 1788- 1799 ,(2011) , 10.1002/CNCR.25738
Emma H. Allott, Lauren E. Howard, Matthew R. Cooperberg, Christopher J. Kane, William J. Aronson, Martha K. Terris, Christopher L. Amling, Stephen J. Freedland, Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. BJUI. ,vol. 114, pp. 661- 666 ,(2014) , 10.1111/BJU.12720
Bernd Kowall, Andreas Stang, Wolfgang Rathmann, Karel Kostev, No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK. Pharmacoepidemiology and Drug Safety. ,vol. 24, pp. 865- 874 ,(2015) , 10.1002/PDS.3823
Kotha Subbaramaiah, Kotha Subbaramaiah, Howard T. Thaler, Baoheng Du, Louise R. Howe, Anthony M. C. Brown, Jaime L. Masferrer, Clifford Hudis, William J. Muller, Andrew J. Dannenberg, Jay Patel, Aparna Deora, Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. Cancer Research. ,vol. 62, pp. 5405- 5407 ,(2002)
Christopher J. Keto, William J. Aronson, Martha K. Terris, Joseph C. Presti, Christopher J. Kane, Christopher L. Amling, Stephen J. Freedland, Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database. BJUI. ,vol. 110, pp. 492- 498 ,(2012) , 10.1111/J.1464-410X.2011.10754.X
Ian J. Neeland, Colby R. Ayers, Anand K. Rohatgi, Aslan T. Turer, Jarett D. Berry, Sandeep R. Das, Gloria L. Vega, Amit Khera, Darren K. McGuire, Scott M. Grundy, James A. de Lemos, Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults Obesity. ,vol. 21, ,(2013) , 10.1002/OBY.20135